David L. DeMets

Changing frequency of interim analysis in sequential monitoring.

D L DeMets, K K Lan, K. K. Lan, 1989, Biometrics.

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

D. DeMets, P. Newcomb, V. Jordan, 1990, Journal of the National Cancer Institute.

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

D. DeMets, S. Zeger, M. Gail, 2001, Controlled clinical trials.

Estimating significance level and power comparisons for testing multiple endpoints in clinical trials.

J Gong, J C Pinheiro, D L DeMets, 2000, Controlled clinical trials.

ACCF/AHA Clinical Practice Guideline Methodology Summit Report: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Deepak L. Bhatt, M. Sayre, E. Antman, 2013, Circulation.